Mannkind (MNKD) Gross Margin (QoQ) (2016 - 2026)

Mannkind (MNKD) Gross Margin (QoQ) (2016 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Mannkind 1.19 Bn 1.08 Bn 94.97 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -485.00
Mar 31, 2026 411.00
Dec 31, 2025 -696.00
Sep 30, 2025 54.00
Jun 30, 2025 -121.00
Mar 31, 2025 145.00
Dec 31, 2024 -170.00
Sep 30, 2024 318.00
Jun 30, 2024 -198.00
Mar 31, 2024 -3,978.00
Dec 31, 2023 6,024.00
Sep 30, 2023 -1,548.00
Jun 30, 2023 287.00
Mar 31, 2023 -229.00
Dec 31, 2022 2,993.00
Sep 30, 2022 4,273.00
Jun 30, 2022 2,215.00
Mar 31, 2022 15,747.00
Dec 31, 2021 -24,644.00
Sep 30, 2021 178.00